PBEAX
Price
$22.78
Change
-$0.36 (-1.56%)
Updated
Sep 6 closing price
VVIAX
Price
$65.30
Change
-$0.84 (-1.27%)
Updated
Sep 6 closing price
Ad is loading...

PBEAX vs VVIAX

Header iconPBEAX vs VVIAX Comparison
Open Charts PBEAX vs VVIAXBanner chart's image
PGIM Jennison Value A
Price$22.78
Change-$0.36 (-1.56%)
VolumeN/A
CapitalizationN/A
Vanguard Value Index Adm
Price$65.30
Change-$0.84 (-1.27%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
PBEAX vs VVIAX Comparison Chart
Loading...
VS
PBEAX vs. VVIAX commentary
Sep 08, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PBEAX is a Buy and VVIAX is a Buy.

FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 183B vs. PBEAX (572M). VVIAX pays higher dividends than PBEAX: VVIAX (2.36) vs PBEAX (0.97). PBEAX was incepted earlier than VVIAX: PBEAX (35 years) vs VVIAX (24 years). PBEAX is a more actively managed with annual turnover of: 28.00 vs. VVIAX (10.00). PBEAX has a lower initial minimum investment than VVIAX: PBEAX (1000) vs VVIAX (3000). VVIAX annual gain was more profitable for investors over the last year : 19.30 vs. PBEAX (15.87). VVIAX return over 5 years is better than : 53.51 vs. PBEAX (25.63).
PBEAXVVIAXPBEAX / VVIAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence35 years24 years-
Gain YTD15.58413.506115%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets572M183B0%
Annual Yield % from dividends0.972.3641%
Returns for 1 year15.8719.3082%
Returns for 3 years3.3219.6817%
Returns for 5 years25.6353.5148%
Returns for 10 years8.66107.578%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GDYN14.080.47
+3.45%
Grid Dynamics Holdings
USEG0.910.01
+1.00%
US Energy Corp
BCE35.950.07
+0.20%
BCE
LNKB6.15N/A
N/A
LINKBANCORP
CRNX50.98-1.82
-3.45%
Crinetics Pharmaceuticals